{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:54:56Z","timestamp":1781877296448,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12166-2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:13:19Z","timestamp":1781874799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis"],"prefix":"10.1007","volume":"53","author":[{"given":"Ruwaidah A.R.","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rounaq A.R.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally S.","family":"mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9549-8339","authenticated-orcid":false,"given":"Sana MH.","family":"Al-Shimmary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"03","key":"12166_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/CM9.0000000000003215","volume":"139","author":"H Gu","year":"2022","unstructured":"Gu H, Wang R, Beeraka NM, Lu P, Zhao X, Li L et al (2022) LEAP2 ameliorates high fat diet-impaired glucose tolerance and enhances glucose-stimulated insulin secretion from \u03b2 cells through PPAR\u03b3 signal pathway. Chin Med J (Engl) 139(03):404\u2013414. https:\/\/doi.org\/10.1097\/CM9.0000000000003215","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"12166_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-025-01741-w","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP et al (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10(1):49. https:\/\/doi.org\/10.1038\/s41392-025-01741-w","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12166_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13072-024-00556-z","volume":"17","author":"R Prabhakaran","year":"2024","unstructured":"Prabhakaran R, Thamarai R, Sivasamy S, Dhandayuthapani S, Batra J, Kamaraj C et al (2024) Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy. Epigenetics Chromatin 17(1):31. https:\/\/doi.org\/10.1186\/s13072-024-00556-z","journal-title":"Epigenetics Chromatin"},{"issue":"4","key":"12166_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040579","volume":"17","author":"\u00c9 M\u00e1rton","year":"2025","unstructured":"M\u00e1rton \u00c9, Varga A, Domoszlai D, Bugly\u00f3 G, Bal\u00e1zs A, Penyige A et al (2025) Non-Coding RNAs in cancer: structure, function, and clinical application. Cancers (Basel) 17(4):579. https:\/\/doi.org\/10.3390\/cancers17040579","journal-title":"Cancers (Basel)"},{"key":"12166_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106168","volume":"144","author":"C Wang","year":"2022","unstructured":"Wang C, Jia Q, Guo X, Li K, Chen W, Shen Q et al (2022) microRNA-34 family: From mechanism to potential applications. Int J Biochem Cell Biol 144:106168. https:\/\/doi.org\/10.1016\/j.biocel.2022.106168","journal-title":"Int J Biochem Cell Biol"},{"issue":"23","key":"12166_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313056","volume":"25","author":"N Maatouk","year":"2024","unstructured":"Maatouk N, Kurdi A, Marei S, Nasr R, Talhouk R (2024) CircRNAs and miRNAs: key player duo in breast cancer dynamics and biomarkers for breast cancer early detection and prevention. Int J Mol Sci 25(23):13056. https:\/\/doi.org\/10.3390\/ijms252313056","journal-title":"Int J Mol Sci"},{"issue":"9","key":"12166_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/COC.0000000000001115","volume":"47","author":"T Zhang","year":"2024","unstructured":"Zhang T, Hu Y, Yang N, Yu S, Pu X (2024) Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy. Am J Clin Oncol 47(9):448\u2013456. https:\/\/doi.org\/10.1097\/COC.0000000000001115","journal-title":"Am J Clin Oncol"},{"issue":"19","key":"12166_CR8","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3390\/cancers15194723","volume":"15","author":"J Fu","year":"2023","unstructured":"Fu J, Imani S, Wu MY, Wu RC (2023) MicroRNA-34 family in cancers: role, mechanism, and therapeutic potential. Cancers (Basel) 15(19):4723. https:\/\/doi.org\/10.3390\/cancers15194723","journal-title":"Cancers (Basel)"},{"issue":"1","key":"12166_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-024-10123-x","volume":"52","author":"P Shaik Syed Ali","year":"2025","unstructured":"Shaik Syed Ali P, Ahmad MP, Parveen KM (2025) Lin28\/let-7 axis in breast cancer. Mol Biol Rep 52(1):1\u20139. https:\/\/doi.org\/10.1007\/s11033-024-10123-x","journal-title":"Mol Biol Rep"},{"issue":"3","key":"12166_CR10","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.48048\/tis.2025.9407","volume":"22","author":"NT Nguyen","year":"2025","unstructured":"Nguyen NT, Huynh LH, Duong TTC, Nguyen TTN, Nguyen HT (2025) Diagnostic and prognostic potential of Let-7 miRNAs in breast cancer: a meta-analysis. Trends Sci 22(3):9407. https:\/\/doi.org\/10.48048\/tis.2025.9407","journal-title":"Trends Sci"},{"issue":"4","key":"12166_CR11","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.7314\/APJCP.2016.17.4.1887","volume":"17","author":"M Behzad","year":"2016","unstructured":"Behzad M, Ali M, Solmaz S, Elham B, Behzad B (2016) Micro RNA 34a and Let-7a expression in human breast cancers is associated with apoptotic expression genes. Asian Pac J Cancer Prev 17(4):1887\u20131890. https:\/\/doi.org\/10.7314\/APJCP.2016.17.4.1887","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"12166_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"10430","key":"12166_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(23)02823-3","volume":"403","author":"M Hickey","year":"2024","unstructured":"Hickey M et al (2024) Managing menopause after cancer. Lancet 403(10430):984\u2013996. https:\/\/doi.org\/10.1016\/S0140-6736(23)02823-3","journal-title":"Lancet"},{"issue":"1","key":"12166_CR14","doi-asserted-by":"publisher","first-page":"2607188","DOI":"10.1080\/07853890.2026.2607188","volume":"58","author":"J Qiu","year":"2026","unstructured":"Qiu J, Wang Z, Ye Y, Yu Y, Chen M, Yang B (2026) Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy. Ann Med 58(1):2607188. https:\/\/doi.org\/10.1080\/07853890.2026.2607188","journal-title":"Ann Med"},{"issue":"3","key":"12166_CR15","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU (2024) Breast cancer: a review of risk factors and diagnosis. Med (Baltim) 103(3):e36905. https:\/\/doi.org\/10.1097\/MD.0000000000036905","journal-title":"Med (Baltim)"},{"issue":"2","key":"12166_CR16","doi-asserted-by":"publisher","first-page":"qdag005","DOI":"10.1093\/jsxmed\/qdag005","volume":"23","author":"Y Liu","year":"2026","unstructured":"Liu Y, Sun D, Wen Y, Zhao H, Long Y, Yu Q et al (2026) The prevalence and risk factors of female sexual dysfunction in breast cancer survivors: a systematic review and meta-analysis. J Sex Med 23(2):qdag005. https:\/\/doi.org\/10.1093\/jsxmed\/qdag005","journal-title":"J Sex Med"},{"key":"12166_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/his.15421","author":"JMB Pang","year":"2026","unstructured":"Pang JMB, Gorringe KL, Tan PH, Fox SB (2026) NTRK \u2010fusion spindle cell tumour in the breast: expanding the differential of challenging spindle cell lesions on core biopsy. Histopathology. https:\/\/doi.org\/10.1111\/his.15421","journal-title":"Histopathology"},{"key":"12166_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2026.101134","volume":"47","author":"N Kim","year":"2026","unstructured":"Kim N, Lukong KE (2026) Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors. Cancer Treat Res Commun 101134. https:\/\/doi.org\/10.1016\/j.ctarc.2026.101134","journal-title":"Cancer Treat Res Commun"},{"issue":"2","key":"12166_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/AJR.20.25223","volume":"217","author":"DC Teichgraeber","year":"2021","unstructured":"Teichgraeber DC, Guirguis MS, Whitman GJ (2021) Breast cancer staging: updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. AJR Am J Roentgenol 217(2):278\u2013290. https:\/\/doi.org\/10.2214\/AJR.20.25223","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"12166_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885\u2013892. https:\/\/doi.org\/10.1001\/jama.285.7.885","journal-title":"JAMA"},{"key":"12166_CR21","unstructured":"Khattab A, Kashyap S, Monga DK Male Breast Cancer. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534827\/"},{"key":"12166_CR22","doi-asserted-by":"publisher","first-page":"108850","DOI":"10.1016\/j.maturitas.2025.108850","volume":"206","author":"L Khatri","year":"2026","unstructured":"Khatri L, Fraker J, Pruthi S (2026) Male breast health and breast cancer risk. Maturitas 206:108850. https:\/\/doi.org\/10.1016\/j.maturitas.2025.108850","journal-title":"Maturitas"},{"issue":"3","key":"12166_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71673","volume":"15","author":"S Iftikhar","year":"2026","unstructured":"Iftikhar S, Burr E, Freigoun A, Nearney T, Kanda CQ, Robinson H et al (2026) Male Breast Cancer: Growing Insights and Continuing Challenges. Cancer Medicine 15(3):e71673. https:\/\/doi.org\/10.1002\/cam4.71673","journal-title":"Cancer Medicine"},{"key":"12166_CR24","doi-asserted-by":"publisher","DOI":"10.1140\/epjs\/s11734-025-01420-x","author":"S Zeneli","year":"2026","unstructured":"Zeneli S, Shyti M, Ikonomi M (2026) Changes in the hormone receptor status of residual breast carcinoma. Eur Phys J Spec Top. https:\/\/doi.org\/10.1140\/epjs\/s11734-025-01420-x","journal-title":"Eur Phys J Spec Top"},{"issue":"1","key":"12166_CR25","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S1470-2045(24)00567-2","volume":"26","author":"R Casolino","year":"2025","unstructured":"Casolino R, Sullivan R, Jobanputra K, Abdel-Wahab M, Grbic M, Hammad N et al (2025) Integrating cancer into crisis: a global vision for action from WHO and partners. Lancet Oncol 26(1):e55\u2013e66. https:\/\/doi.org\/10.1016\/S1470-2045(24)00567-2","journal-title":"Lancet Oncol"},{"issue":"10","key":"12166_CR26","doi-asserted-by":"publisher","first-page":"101042832096446","DOI":"10.1177\/1010428320964467","volume":"42","author":"AM Ibrahim","year":"2020","unstructured":"Ibrahim AM, Said MM, Hilal AM, Medhat AM, Elsalam IMA (2020) Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients. Tumour Biol 42(10):1010428320964467. https:\/\/doi.org\/10.1177\/1010428320964467","journal-title":"Tumour Biol"},{"issue":"2","key":"12166_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020156","volume":"17","author":"G Rinnerthaler","year":"2016","unstructured":"Rinnerthaler G, Hackl H, Gampenrieder SP, Hamacher F, Hufnagl C, Hauser-Kronberger C et al (2016) miR-16-5p is a stably-expressed housekeeping microRNA in breast cancer tissues from primary tumors and from metastatic sites. Int J Mol Sci 17(2):156. https:\/\/doi.org\/10.3390\/ijms17020156","journal-title":"Int J Mol Sci"},{"key":"12166_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26685\/urncst.342","volume":"6","author":"N Mehta","year":"2022","unstructured":"Mehta N (2022) RT-qPCR made simple: a comprehensive guide on the methods, advantages, disadvantages, and everything in between. Undergrad Res Nat Clin Sci Technol J 6:1\u20136. https:\/\/doi.org\/10.26685\/urncst.342","journal-title":"Undergrad Res Nat Clin Sci Technol J"},{"issue":"2","key":"12166_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5603\/rpor.100214","volume":"30","author":"P Vats","year":"2025","unstructured":"Vats P, Baweja B, Nirmal S, Singh A, Nema R (2025) TMPO-AS1-hsa-let-7b-5p-EZH2-RNA network predicts poor survival in basal-like breast cancer patients. Rep Pract Oncol Radiother 30(2):185\u2013201. https:\/\/doi.org\/10.5603\/rpor.100214","journal-title":"Rep Pract Oncol Radiother"},{"issue":"16","key":"12166_CR30","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1002\/cam4.2575","volume":"8","author":"M Li","year":"2019","unstructured":"Li M, Zou X, Xia T, Wang T, Liu P, Zhou X et al (2019) Increased risk for other cancers in individuals with Ewing sarcoma and their relatives. Cancer Medicine 8(16):7006\u20137017. https:\/\/doi.org\/10.1002\/cam4.2575","journal-title":"Cancer Medicine"},{"key":"12166_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2025.102211","volume":"40","author":"V Tavakolpour","year":"2025","unstructured":"Tavakolpour V, Safari-Kharkeshi M, Soleimanpour-Lichaei HR, Gardaneh M, Kouhkan F (2025) MicroRNA-34a enhances immune response and suppresses PI3K\/AKT signaling through targeting PD-L1 in triple-negative breast cancer. Gene Reports 40:102211. https:\/\/doi.org\/10.1016\/j.genrep.2025.102211","journal-title":"Gene Reports"},{"issue":"1","key":"12166_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10549-023-07185-1","volume":"204","author":"SM Yahya","year":"2024","unstructured":"Yahya SM, Nabih HK, Elsayed GH, Mohamed SIA, Elfiky AM, Salem SM (2024) Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene. Breast Cancer Res Treat 204(1):133\u2013149. https:\/\/doi.org\/10.1007\/s10549-023-07185-1","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"12166_CR33","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.62347\/PHYS4309","volume":"16","author":"Y Hong","year":"2024","unstructured":"Hong Y, Chen T, He Q, Ma Q, Chen Z (2024) Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy. Am J Transl Res 16(6):2711\u20132720","journal-title":"Am J Transl Res"},{"key":"12166_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101651","volume":"54","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen P, Yang J (2020) MiR-451a suppresses the development of breast cancer via targeted inhibition of CCND2. Mol Cell Probes 54:101651. https:\/\/doi.org\/10.1016\/j.mcp.2020.101651","journal-title":"Mol Cell Probes"},{"issue":"9","key":"12166_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093045","volume":"21","author":"Y Tokumaru","year":"2020","unstructured":"Tokumaru Y, Katsuta E, Oshi M, Sporn JC, Yan L, Le L et al (2020) High expression of miR-34a associated with less aggressive cancer biology but not with survival in breast cancer. Int J Mol Sci 21(9):3045. https:\/\/doi.org\/10.3390\/ijms21093045","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12166_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/diagnostics11010107","volume":"11","author":"J Kim","year":"2021","unstructured":"Kim J (2021) Identification of MicroRNAs as diagnostic biomarkers for breast cancer based on the cancer genome atlas. Diagnostics (Basel) 11(1):107. https:\/\/doi.org\/10.3390\/diagnostics11010107","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"12166_CR37","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/biom14111352","volume":"14","author":"M Samara","year":"2024","unstructured":"Samara M, Thodou E, Patoulioti M, Poultsidi A, Thomopoulou GE, Giakountis A (2024) Integrated miRNA Signatures: Advancing Breast Cancer Diagnosis and Prognosis. Biomolecules 14(11):1352. https:\/\/doi.org\/10.3390\/biom14111352","journal-title":"Biomolecules"},{"issue":"14","key":"12166_CR38","doi-asserted-by":"publisher","first-page":"23177","DOI":"10.18632\/oncotarget.15520","volume":"8","author":"S Imani","year":"2017","unstructured":"Imani S, Zhang X, Hosseinifard H, Fu S, Fu J (2017) The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis. Oncotarget 8(14):23177\u201323187. https:\/\/doi.org\/10.18632\/oncotarget.15520","journal-title":"Oncotarget"},{"issue":"32","key":"12166_CR39","doi-asserted-by":"publisher","first-page":"22523","DOI":"10.18632\/oncotarget.25191","volume":"9","author":"M Zaleski","year":"2018","unstructured":"Zaleski M, Kobilay M, Schroeder L, Debald M, Semaan A, Hettwer K et al (2018) Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15\u2009\u2013\u20093 or CEA. Oncotarget 9(32):22523\u201322536. https:\/\/doi.org\/10.18632\/oncotarget.25191","journal-title":"Oncotarget"},{"issue":"1","key":"12166_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12885-022-09692-x","volume":"22","author":"E Sehovic","year":"2022","unstructured":"Sehovic E, Urru S, Chiorino G, Doebler P (2022) Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection. BMC Cancer 22(1):634. https:\/\/doi.org\/10.1186\/s12885-022-09692-x","journal-title":"BMC Cancer"},{"issue":"4","key":"12166_CR41","doi-asserted-by":"publisher","first-page":"e38214","DOI":"10.1016\/j.heliyon.2025.e38214","volume":"11","author":"Z Sadeghi","year":"2025","unstructured":"Sadeghi Z, Malekzadeh M, Sharifi M, Hashemibeni B (2025) The role of miR-16 and miR-34a family in the regulation of cancers: A review. Heliyon 11(4):e38214. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e38214","journal-title":"Heliyon"},{"issue":"1","key":"12166_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12967-023-04074-x","volume":"21","author":"I Barone","year":"2023","unstructured":"Barone I, Gelsomino L, Accattatis FM, Giordano F, Gyorffy B, Panza S et al (2023) Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a. J Transl Med 21(1):232. https:\/\/doi.org\/10.1186\/s12967-023-04074-x","journal-title":"J Transl Med"},{"issue":"1","key":"12166_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.20517\/evcna.2024.52","volume":"6","author":"CP de Rezende","year":"2025","unstructured":"de Rezende CP, de Lima Alves D, de Almeida Chuffa LG, de Campos Zuccari DAP (2025) Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives. Extracell Vesicles Circ Nucleic Acids 6(1):54\u201372. https:\/\/doi.org\/10.20517\/evcna.2024.52","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"issue":"9","key":"12166_CR44","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.31557\/APJCP.2019.20.9.2749","volume":"20","author":"NM Kassem","year":"2019","unstructured":"Kassem NM, Makar WS, Kassem HA, Talima S, Tarek M, Hesham H et al (2019) Circulating miR-34a and miR-125b as promising non-invasive biomarkers in Egyptian locally advanced breast cancer patients. Asian Pac J Cancer Prev 20(9):2749\u20132754. https:\/\/doi.org\/10.31557\/APJCP.2019.20.9.2749","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"12166_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250642","volume":"16","author":"SH Ahmed","year":"2021","unstructured":"Ahmed SH, Espinoza-S\u00e1nchez NA, El-Damen A, Fahim SA, Badawy MA, Greve B et al (2021) Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer. PLoS One 16(4):e0250642. https:\/\/doi.org\/10.1371\/journal.pone.0250642","journal-title":"PLoS One"},{"issue":"5","key":"12166_CR46","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s12035-015-9184-7","volume":"53","author":"L Kumar","year":"2016","unstructured":"Kumar L, Haque R, Nazir A (2016) Role of microRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview. Mol Neurobiol 53(5):2787\u20132793. https:\/\/doi.org\/10.1007\/s12035-015-9184-7","journal-title":"Mol Neurobiol"},{"key":"12166_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.640587","volume":"9","author":"W Li","year":"2021","unstructured":"Li W, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ et al (2021) MicroRNA-34a: Potent tumor suppressor, cancer stem cell inhibitor, and potential anticancer therapeutic. Front Cell Dev Biol 9:640587. https:\/\/doi.org\/10.3389\/fcell.2021.640587","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"12166_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098392","volume":"24","author":"NK Sedky","year":"2023","unstructured":"Sedky NK, Abdel-Kader NM, Issa MY, Abdelhady MMM, Shamma SN, Bakowsky U et al (2023) Co-delivery of Ylang Ylang oil of Cananga odorata and Oxaliplatin using intelligent pH-sensitive lipid-based nanovesicles for the effective treatment of triple-negative breast cancer. Int J Mol Sci 24(9):8392. https:\/\/doi.org\/10.3390\/ijms24098392","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12166_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061355","volume":"12","author":"YJ Kwon","year":"2020","unstructured":"Kwon YJ, Cho YE, Cho AR, Choi WJ, Yun S, Park H et al (2020) The possible influence of Mediterranean diet on extracellular vesicle miRNA expression in breast cancer survivors. Cancers (Basel) 12(6):1355. https:\/\/doi.org\/10.3390\/cancers12061355","journal-title":"Cancers (Basel)"},{"issue":"1","key":"12166_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4149\/neo_2018_180302N146","volume":"66","author":"Y Mi","year":"2019","unstructured":"Mi Y, Liu F, Liang X et al (2019) Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1. Neoplasma 66(1):54\u201362. https:\/\/doi.org\/10.4149\/neo_2018_180302N146","journal-title":"Neoplasma"},{"issue":"5","key":"12166_CR51","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.21037\/tcr.2019.08.30","volume":"8","author":"C Liu","year":"2019","unstructured":"Liu C, Chen Z, Fang M, Qiao Y (2019) MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression. Transl Cancer Res 8(5):1763\u20131771. https:\/\/doi.org\/10.21037\/tcr.2019.08.30","journal-title":"Transl Cancer Res"},{"issue":"12","key":"12166_CR52","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.26355\/eurrev_201906_18197","volume":"23","author":"J Du","year":"2019","unstructured":"Du J, Fan JJ, Dong C, Li HT, Ma BL (2019) Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc. Eur Rev Med Pharmacol Sci 23(12):5301\u20135314. https:\/\/doi.org\/10.26355\/eurrev_201906_18197","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"12166_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202000066","volume":"1","author":"M Sun","year":"2021","unstructured":"Sun M et al (2021) 3D cell culture\u2014can it be as popular as 2D cell culture? Adv Nanobiomed Res 1(5):2000066. https:\/\/doi.org\/10.1002\/anbr.202000066","journal-title":"Adv Nanobiomed Res"},{"issue":"19","key":"12166_CR54","doi-asserted-by":"publisher","first-page":"28480","DOI":"10.1007\/s11356-021-18434-x","volume":"29","author":"Z Ren","year":"2022","unstructured":"Ren Z, Xu Y, Wang X, Ren M (2022) KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a \/ Notch3 axis in breast cancer. Environ Sci Pollut Res Int 29(19):28480\u201328494. https:\/\/doi.org\/10.1007\/s11356-021-18434-x","journal-title":"Environ Sci Pollut Res Int"},{"issue":"4","key":"12166_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15155","volume":"9","author":"W Pan","year":"2023","unstructured":"Pan W, Chai B, Li L, Lu Z, Ma Z (2023) p53\/MicroRNA-34 axis in cancer and beyond. Heliyon 9(4):e15155. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15155","journal-title":"Heliyon"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12166-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12166-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12166-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:13:23Z","timestamp":1781874803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12166-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12166"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12166-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"It is approved to publish, as no individual personal data is included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"958"}}